With all the expectations for available Covid-19 vaccines based on the successful late-stage trial results reported by Pfizer/BioNTech and Moderna, the looming question is: when will the public be able to start getting the vaccines?
North Dakota became the 35th U.S. state to require face coverings be worn in public, as governors across the country grapple with a surge in coronavirus infections that threatens to swamp their healthcare systems.
The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention presented details about Covid-19 and the requirements for a vaccine in a nine-hour virtual meeting.
Nearly 300,000 more people have died in the United States in 2020 during the coronavirus pandemic than expected based on historical trends, with about two-thirds of the deaths due to Covid-19 illnesses, according to a report.
President Donald Trump, under fire over his handling of the coronavirus epidemic, announced that the federal government would ship 150 million rapid tests to U.S. states and warned an increase in positive cases is likely in the days ahead.
A top U.S. health official told a U.S. Senate committee that he expects Covid-19 vaccinations to take place over many months and that most Americans could be vaccinated by July 2021 at the latest.
The U.S. Centers for Disease Control and Prevention (CDC) set an Oct. 16 deadline for states to submit plans for distributing Covid-19 vaccines – even before it becomes clear when any will be available – according to a presentation to a panel of experts who make recommendations on U.S. vaccines.
The death toll from the spread of the coronavirus in the United States exceeded 200,000, by the far the highest number of any nation.
A Covid-19 vaccine could be broadly rolled out in the United States by the middle of 2021 or a little later, the head of the federal government’s disease control agency said.
The U.S. Centers for Disease Control and Prevention (CDC) asked state public health officials to prepare to distribute a potential coronavirus vaccine to high-risk groups as soon as late October, documents published by the agency showed.